Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 03 - 30 tags : Treatment save search
Dental Lasers Deliver Consistent Results, Comfort for Patients and Myriad Treatment Capabilities for Providers
Published: 2021-03-30 (Crawled : 01:00) - biolase.com
BIOL | $0.1412 -4.92% -5.17% 1.4M
|
Health Technology
|
| O: 2.29%
H: 0.0%
C: -1.31%
treatment laser liver
Jazz Pharmaceuticals Announces FDA Approval of Additional Indication for Vyxeos® (daunorubicin and cytarabine) for the Treatment of Secondary Acute Myeloid Leukemia in Pediatric Patients
Published: 2021-03-30 (Crawled : 23:00) - prnewswire.com
JAZZ | $109.96 0.63% 0.63% 760K
|
Health Technology
|
| O: 0.37%
H: 0.84%
C: -1.63%
treatment fda myeloid leukemia fda approval leukemia approval acute myeloid leukemia
Surface Oncology’s SRF617 Receives Orphan Drug Designation from FDA for Treatment of Pancreatic Cancer
Published: 2021-03-30 (Crawled : 21:00) - globenewswire.com
SURF | $1.07 -0.93% -1.41% 0
|
Health Technology
|
| O: 14.07%
H: 2.3%
C: -5.68%
treatment fda cancer drug pancreatic pancreas designation
Biotechs Working on Potential Preventive Measures and Cancer Treatments
Published: 2021-03-30 (Crawled : 13:00) - prnewswire.com
SNDX | $20.82 1.61% 1.59% 850K
|
Health Technology
|
| O: -2.5%
H: 2.66%
C: -2.33%
SLS | $1.525 0.33% 0.33% 1.8M
|
Health Technology
|
| O: -1.14%
H: 6.4%
C: 2.69%
NKTR | News | $1.265 -4.17% -4.35% 4.7M
|
Health Technology
|
| O: -0.41%
H: 1.82%
C: 0.1%
CLDX | $37.98 -1.43% -1.45% 590K
|
Health Technology
|
| O: -6.36%
H: 6.27%
C: 2.93%
treatment potential cancer biotech iot
Evoke Pharma Announces a Fireside Chat with Key Opinion Leaders on the Treatment of Gastroparesis
Published: 2021-03-30 (Crawled : 13:00) - globenewswire.com
EVOK | $0.493 2.97% 2.88% 1.9K
|
Health Technology
|
| O: -1.11%
H: 0.56%
C: -0.56%
treatment pharma
Krystal Biotech Announces Completion of Patient Enrollment in the GEM-3 Pivotal Trial of B-VEC for the Treatment of Dystrophic Epidermolysis Bullosa
Published: 2021-03-30 (Crawled : 12:15) - globenewswire.com
KRYS | $158.63 -3.26% -3.37% 340K
|
Health Technology
|
| O: -0.04%
H: 7.03%
C: 5.45%
treatment biotech iot trial enroll
Corbus Pharmaceuticals Reports Last Subject Visit in DETERMINE Phase 3 Study of Lenabasum for Treatment of Dermatomyositis
Published: 2021-03-30 (Crawled : 12:00) - globenewswire.com
CRBP | $39.12 7.09% 6.62% 280K
|
Health Technology
|
| O: -2.78%
H: 6.86%
C: 5.71%
treatment phase 3
St. Paul Selects Jacobs as Design-Build Firm in Water Treatment Reliability Milestone
Published: 2021-03-30 (Crawled : 12:00) - prnewswire.com
J | News | $143.83 0.23% 0.0% 380K
|
Industrial Services
|
| O: 0.0%
H: 0.88%
C: 0.6%
treatment milestone designation
Moleculin Receives FDA Approval of Fast Track Designation for Annamycin in the Treatment of Sarcoma Lung Metastases
Published: 2021-03-30 (Crawled : 12:00) - prnewswire.com
MBRX | $4.65 2.8% 2.72% 11K
|
Health Technology
|
| O: 21.89%
H: 5.76%
C: -5.76%
treatment fda fast track fda approval approval fast track designation designation
Intellia Therapeutics’ Investigational CRISPR Treatment NTLA-2001 Receives European Union Orphan Drug Designation for ATTR Amyloidosis
Published: 2021-03-30 (Crawled : 12:00) - globenewswire.com
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: -0.35%
H: 0.21%
C: -1.91%
NTLA | $21.57 1.17% 1.16% 1.4M
|
Health Technology
|
| O: -0.7%
H: 12.26%
C: 11.4%
crispr treatment drug designation
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.